Wall Street’s Top Analysts Upgrades, Downgrades & Initiations
$AMZN, $ABC, $BK, $DOV, $NKE, $NVDA
Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of Wall Streets top analysts upgrades, downgrades and initiations for Thursday, as follows:
Amazon.com Inc. (NASDAQ:AMZN) analyst reiterated with a Buy rating at Cantor Fitz and is a top pick at Evercore for Y 2017. The Wall Street consensus price target for the technology giant is at 929. The 52-wk trading range for the shares is 474 – 847.21.
AmerisourceBergen Corp. (NYSE:ABC) analysts reiterated a Buy rating at Argus, and the firm revised its price target to 120. That compares with a consensus price target of 85.33. The 52-wk trading range for the shares is 63.38 – 105.81.
Bank of New York Mellon Corp. (NYSE:BK) was raised to Strong Buy from Outperform at Raymond James. The analysts also raised their price target to 75 from 50. The consensus target is 51.17, and the 52-wk trading range is 32.20 – 49.54.
Dover Corp. (NYSE:DOV) is a top idea for Y 2017 at Baird. The firm reiterates its Outperform rating and 85 price target. That compares with a 76.16 consensus Wall Street price objective. The 52-wk range is 50.91 – 71.87.
Nike Corp. (NYSE:NKE) was reiterated with an Outperform rating at Credit Suisse, but the analysts lowered their price target to 60. The consensus price target is at 62. The 52-wk trading range is 49.01 – 65.44.
NVIDIA Corp. (NASDAQ:NVDA) is on fire. The analysts at Argus see continued momentum for the shares in Y 2017 and they raise their price target to 130 from 95. That Vs a consensus price objective at 92.65. The 52-wk trading range is 24.75 – 117.36.
Latest posts by Paul Ebeling (see all)
- Capitalism is the ‘Greatest Show’ on Earth - April 27, 2017
- Healing: Tap into the Mind Body Connection Along with Conventional Medicine - April 27, 2017
- Italian Style Coffee Lowers Risk of Prostate Cancer - April 27, 2017